Literature DB >> 12859269

Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.

Robert F Degenring1, Bernd Kamppeter, Ingrid Kreissig, Jost B Jonas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12859269     DOI： 10.1034/j.1600-0420.2003.00084.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN： 1395-3907


× No keyword cloud information.
  4 in total

1.  Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors.

Authors:  Ziad F Bashshur; Abdallah M Terro; Christelle P El Haibi; Akaber M Halawi; Alexandre Schakal; Baha' N Noureddin
Journal:  Clin Ophthalmol       Date:  2008-06

2.  Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).

Authors:  Gary Edd Fish
Journal:  Trans Am Ophthalmol Soc       Date:  2008

3.  Early versus late intravitreal triamcinolone acetonide for macular edema associated with branch retinal vein occlusion.

Authors:  Joo Youn Oh; Je Hyun Seo; Jae Kyoun Ahn; Jang Won Heo; Hum Chung
Journal:  Korean J Ophthalmol       Date:  2007-03

Review 4.  Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities.

Authors:  Jiri Rehak; Matus Rehak
Journal:  Curr Eye Res       Date:  2008-02       Impact factor: 2.424
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.